LY-3844583

N/A

Report date: 2024/11/15 09:47:23

Base Information

Drug NameLY-3844583
Drug Alias NameLY-3844583LY3844583
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionGlucocorticoid-induced tumor necrosis factor receptor-related protein inhibitors
TargetsGlucocorticoid-induced tumor necrosis factor receptor-related protein
Therapy Area/IndicationsDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsDermatitis, Atopic

Other Information

ATC CodeN/A
Related LinksN/A